(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-bromophenyl)propanoic acid, 98%, 250mg

CIS-3-HEXENYL SALICYLATE, 95.0%, 100g

5-(4-methoxy-3-nitrophenyl)-1H-pyrazole-4-carboxylic acid, 95.0%, 1g

1H-Pyrazole-5-carboxylic acid methyl ester, 97.0%, 5g

N1-(1-benzylpiperidin-4-yl)benzene-1,2-diamine, 95+%, 1g

2-Bromo-5-fluorobenzyl bromide, 98.0%, 5g

Methyl 2-amino-4-methyl-3-thiophenecarboxylate, 95.0%, 1g

1-Amino-N-methylcyclopropane-1-carboxamide, 98%, 1g

1-Boc-4-(carboxythiophen-2-yl-methyl)-[1,4]diazepane, 1g

(3R,5S,6E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[(METHANESULFONYL) METHYLAMINO]PYRIMIDIN-5-YL]-3,5-DIHYDROXYHEPT-6-ENOIC ACID TERT-BUTYL ESTER, 95%, 5g

1-(4-Bromobutyl)-2-chlorobenzene, 98%, 500mg

Pipetas volumétricas 1 marca clase AS, 40 ml, 6 piezas

Tamiz molecular de 10 Å, 1,0 nm, tipo 544, forma de perlas, 250 g, envase de vidrio